IP Library › Patent Application 10936319
Patent Application
App. No. 10/936,319

Oral administration of beta-carotene, lycopene and lutein for human skin protection

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
10/936,319
Abstract

Methods of improving the sun protection factor of human skin and methods of inhibiting the aging of human skin via the oral administration of a composition comprising (a) β-carotene, (b) lutein and (c) lycopene, in a ratio by weight (a):(b):(c) of from 1:0.5:0.5 to 1:1.5:1.5 are described.

Claims (15)

1 - 7 . (canceled).

8 . A method of improving the sun protection factor of human skin, the method comprising:

(i) providing a composition comprising (a) β-carotene, (b) lutein and (c) lycopene, in a ratio by weight (a):(b):(c) of from 1:0.5:0.5 to 1:1.5:1.5; and

(ii) orally administering the composition to a human.

9 . The method according to claim 8 , wherein the composition further comprises one or more components selected from the group consisting of α-carotene, astaxanthin, α-cryptoxanthin, β-cryptoxanthin, zeaxanthin, phytoene, phtyofluene, γ-carotene and neurosporin.

10 . The method according to claim 8 , wherein the β-carotene, the lutein and the lycopene in a ratio by weight of from 1:0.5:0.5 to 1:1.0:1.0.

11 . The method according to claim 8 , wherein the composition is dispersed in an edible oil.

12 . The method according to claim 8 , wherein the β-carotene, the lutein and the lycopene are each present in an amount of from 1 to 40 mg.

13 . A method of inhibiting the aging of human skin, the method comprising:

(i) providing a composition comprising (a) β-carotene, (b) lutein and (c) lycopene, in a ratio by weight (a):(b):(c) of from 1:0.5:0.5 to 1:1.5:1.5; and

(ii) orally administering the composition to a human.

14 . The method according to claim 13 , wherein the composition further comprises one or more components selected from the group consisting of α-carotene, astaxanthin, α-cryptoxanthin, β-cryptoxanthin, zeaxanthin, phytoene, phtyofluene, γ-carotene and neurosporin.

15 . The method according to claim 13 , wherein the β-carotene, the lutein and the lycopene in a ratio by weight of from 1:0.5:0.5 to 1:1.0:1.0.

16 . The method according to claim 13 , wherein the composition is dispersed in an edible oil.

17 . The method according to claim 13 , wherein the β-carotene, the lutein and the lycopene are each present in an amount of from 1 to 40 mg.